CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease. Issue 10 (29th July 2013)

• Record Type: Journal Article
• Authors: Semaka, Alicia; Kay, Chris; Doty, Crystal; Collins, Jennifer A; Bijlsma, Emilia K; Richards, Fiona; Goldberg, Y Paul; Hayden, Michael R
• Is Part Of: Journal of medical genetics. Volume 50:Issue 10(2013)
• Page Start: 696
• Page End: 703
• Publication Date: 2013-07-29
• Subjects: Huntington disease -- Intermediate alleles -- CAG repeat instability -- New mutations -- Genetic counselling; Medical genetics -- Periodicals; 616.042
• DOI: 10.1136/jmedgenet-2013-101796
• Languages: English
• ISSNs: 1468-6244

Abstract

Abstract : Introduction: New mutations for Huntington disease (HD) occur due to CAG repeat instability of intermediate alleles (IA). IAs have between 27 and 35 CAG repeats, a range just below the disease threshold of 36 repeats. While they usually do not confer the HD phenotype, IAs are prone to paternal germline CAG repeat instability. Consequently, they may expand into the HD range upon transmission to the next generation, producing a new mutation. Quantified risk estimates for IA repeat instability are extremely limited but needed to inform clinical practice. Methods: Using small-pool PCR of sperm DNA from Caucasian men, we examined the frequency and magnitude of CAG repeat instability across the entire range of intermediate CAG sizes. The CAG size-specific risk estimates generated are based on the largest sample size ever examined, including 30 IAs and 18 198 sperm. Results: Our findings demonstrate a significant risk of new mutations. While all intermediate CAG sizes demonstrated repeat expansion into the HD range, alleles with 34 and 35 CAG repeats were associated with the highest risk of a new mutation (2.4% and 21.0%, respectively). IAs with ≥33 CAG repeats showed a dramatic increase in the frequency of instability and a switch towards a preponderance of repeat expansions over contractions. Conclusions: These data provide novel insights into the origins of new mutations for HD. The CAG size-specific risk estimates inform clinical practice and provide accurate risk information for persons who receive an IA predictive test result.